Yirui Hu

Yirui Hu

Auto-generated profile, based on publicly available information

Yirui Hu

Department of Population Health Sciences, Geisinger, Danville, PA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2017 in Dementia and Geriatric Cognitive Disorders Extra
Verified
Journal Article
Open access
PDF file
JWJingkai Wei
Jingkai Wei
YHYirui Hu
Yirui Hu
LZLi Zhang
Li Zhang
QHQiang Hao
Qiang Hao
RYRuowei Yang
Ruowei Yang
ECEeshwar K. Chandrasekar
Eeshwar K. Chandrasekar
Background: To estimate a pooled association between hearing impairment and risk of mild cognitive impairment and dementia. Methods: PubMed, Embase, and Web of Science were searched for prospective cohort studies that examined the association between hearing impairment and risk of mild cognitive impairment and/or dementia. Random-effects models were fitted to estimate the summary risk ratios (RRs) and 95% confidence interval (CIs), which represents the pooled association between hearing impairment with risk of mild cognitive impairment and dementia, compared to subjects free of hearing impairment. Results: Four studies on hearing impairment with mild cognitive impairment and 7 studies on hearing impairment with dementia were included in the meta-analysis. A total of 15,521 subjects were studied with follow-up periods between 2 and 16.8 years. Hearing impairment was associated with a greater risk of mild cognitive impairment (RR = 1.30, 95% CI: 1.12, 1.51) and dementia (RR = 2.39, 95% CI: 1.58, 3.61). Conclusions: The meta-analysis showed that hearing impairment is associated with a higher risk of mild cognitive impairment and dementia among older adults.

1 November 2018 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
MLMichelle R. Lent
Michelle R. Lent
YHYirui Hu
Yirui Hu
PBPeter N. Benotti
Peter N. Benotti
APAnthony T. Petrick
Anthony T. Petrick
GWG. Craig Wood
G. Craig Wood
HKH. Lester Kirchner
H. Lester Kirchner

26 December 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ADAntoinette Sabatino DiCriscio
Antoinette Sabatino DiCriscio
YHYirui Hu
Yirui Hu
VTVanessa Troiani
Vanessa Troiani
We assessed whether there are differences in pupil response that underlie the selection of local vs. global parts of a stimulus array in healthy adults. We designed a Navon Figures eyetracking paradigm (i.e. large figure composed of small figures), requiring an individual to vary only the information attended to within an image. We found that participants have a characteristic constriction of the pupil waveform during selection of local information relative to global information. Because stimuli and lighting conditions were identical across conditions, this indicates that pupil changes may serve in a visual filtering mechanism important for attentional selection. This work represents the first characterization of pupil response in the context of selective attention, suggesting that mechanisms underlying the earliest stages of visual processes could be relevant for perception and visual selection.

25 January 2022 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
WPWeihua Pan
Weihua Pan
YHYirui Hu
Yirui Hu
LWLihong Wang
Lihong Wang
JLJing Li
Jing Li

17 June 2021 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
KCK.A. Cauley
K.A. Cauley
YHY. Hu
Y. Hu
SFS.W. Fielden
S.W. Fielden
Inflammatory bowel disease (IBD) is an emerging global disease characterised by chronic inflammation of the gastrointestinal tract. However, IBD is also manifested by several extraintestinal symptoms which, along with the intestinal symptoms, impact on the mental and emotional well-being of patients. Despite therapeutic advancements, only one-third of the diagnosed patients receiving approved medical treatments achieve short-term to medium-term remission. Consequently, patients who do not get successfully treated might resort to using complementary and alternative approaches to manage their symptoms, with or without consulting their treating clinician. Despite their possible potential, such approaches have various risks stemming from unknown adverse reactions and possible interference with medically approved therapies. In this study, we present the results of a well-performed literature review where we included randomised clinical trials which have assessed the efficacy of complementary approaches and dietary therapy on at least one of the following four outcomes: clinical remission, endoscopic remission, modulation of molecular biomarkers or quality of life metrics. By pointing out intraoutcome and interoutcome concordance, we identified possible candidates for clinical adoption and further study in larger randomised clinical trials covering the broad spectrum of IBD heterogeneity. We finally proposed a patient-centric clinical care model and a series of recommendations for stakeholders, with special attention to complementary approaches and dietary strategies, aimed at achieving holistic remission.

1 January 2020 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
YHYirui Hu
Yirui Hu
XCXin Chu
Xin Chu
TUThomas G Urosevich
Thomas G Urosevich
SHStuart N Hoffman
Stuart N Hoffman
H. Lester KirchnerH. Lester Kirchner
H. Lester Kirchner
JBJoseph A Boscarino
Joseph A Boscarino
Background: Previously we reported a genetic risk score significantly improved PTSD prediction among a trauma-exposed civilian population. In the current study, we sought to assess this prediction among a trauma-exposed military population. Methods: We examined current PTSD diagnosis and PTSD symptom severity among a random sample of 1042 community-based US military veterans. Main effects and interaction effects were assessed for PTSD genetic risk by trauma exposure using cross-product terms for PTSD x trauma exposures, including combat, lifetime trauma, and adverse childhood exposures. The PTSD risk variants studied were within genetic loci previously associated with PTSD, including CRHR1, CHRNA5, RORA, and FKBP5 genetic variants, which were used to calculate a total PTSD genetic risk score (range=0–8, mean=3.6, SD=1.4). Results: Based on DSM-5 PTSD criteria, 7.1% of veterans (95% CI=5.6–8.8) met criteria for current PTSD. The PTSD genetic risk count was significantly higher among PTSD cases vs non-cases (3.92 vs 3.55, p=0.027). Since the PTSD genetic risk score was not significant in the PTSD diagnosis model, we assessed this association using PTSD symptom severity. Because these symptom data were skewed (mean=9.54, SD=12.71, range=0–76), we used negative binomial regression to assess this outcome. This symptom model included a PTSD genetic risk score, demographic factors, trauma exposures, current insomnia, current depression, concussion history, and attention-deficit disorder, expressed as incident rate ratios (IRR), which is an estimate of one-unit increase in PTSD severity, given other variables are held constant. Variables in the final model included age and sex (both p<0.001), PTSD genetic risk (IRR=1.02, p=0.028), warzone tours (IRR=0.94, p=0.003), childhood abuse (IRR=1.50, p<0.0001), current depression (IRR=1.89, p<0.0001), current insomnia (IRR=2.58, p<0.0001), low social support (IRR=1.19, p<0.0001), attention-deficit disorder (IRR=1.51, p<0.0001), agreeable personality (IRR=0.77, p<0.0001), and concussion (IRR=1.38, p<0.0001). Significant interactions were detected for combat and lifetime trauma exposure by PTSD genetic risk (both p<0.0001), suggesting that the impact of trauma exposures on PTSD severity was lower when the PTSD genetic risk was higher. Conclusion: Both warzone and non-warzone factors predicted current PTSD symptoms among veterans, including a PTSD genetic risk score. Interaction effects were detected for combat exposure and lifetime trauma by genetic risk score for PTSD symptoms, suggesting that PTSD symptom manifestation was more dependent on PTSD risk variants than the level of trauma or combat exposure. This suggests that controlling for other factors, the absence of genetic risk variants may confer PTSD resilience. Further research is planned.